Functional Analysis of the Putative Tumor Suppressor PTPRD in Neuroblastoma Cells

REFERENCES

• Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nature Reviews Cancer 2003;3:203.
   PubMed Web of Science ®Google Scholar
• Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010;362:2202.
   PubMed Web of Science ®Google Scholar
• Janoueix-Lerosey I, Schleiermacher G, Delattre O. Molecular pathogenesis of peripheral neuroblastic tumors. Oncogene 2010;29:1566.
   PubMed Web of Science ®Google Scholar
• Chen L, Malcolm AJ, Wood KM, Cole M, Variend S, Cullinane C, Pearson ADJ, Lunec J, Tweddle DA. p53 is nuclear and functional in both undifferentiated and differentiated neuroblastoma. Cell Cycle 2007;6:2685.
   PubMed Web of Science ®Google Scholar
• Beltinger CP, White PS, Sulman EP, Maris JM, Brodeur GM. No CDKN2 mutations in neuroblastomas. Cancer Res 1995;55:2053.
   PubMed Web of Science ®Google Scholar
• Muñoz J, Lázcoz P, Inda MM, Nistal M, Pestaña A, Encío IJ, Castresana JS. Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines. Int J Cancer 2004;109:673.
   PubMed Web of Science ®Google Scholar
• Laczmanska I, Sasiadek MM. Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer. Acta Biochimica Polonica 2011;58:467.
   PubMed Web of Science ®Google Scholar
• Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S, Ptak J, Silliman N, Peters BA, van der Heijden MS, Parmigiani G, Yan H, Wang TL, Riggins G, Powell SM, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004;304:1164.
   PubMed Web of Science ®Google Scholar
• Julien SG, Dubé N, Hardy S, Tremblay ML. Inside the human cancer tyrosine phosphatome. Nature Reviews Cancer 2011;11:35.
   PubMed Web of Science ®Google Scholar
• Solomon DA, Kim J-S, Cronin JC, Sibenaller Z, Ryken T, Rosenberg SA, Ressom H, Jean W, Bigner D, Yan H, Samuels Y, Waldman T. Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma. Cancer Res 2008;68:10300.
   PubMed Web of Science ®Google Scholar
• Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB, Paty PB, Rohle D, Vivanco I, Chmielecki J, Pao W, Ladanyi M, Gerald WL, Liau L, Cloughesy TC, Mischel PS, Sander C, Taylor B, Schultz N, Major J, Heguy A, Fang F, Mellinghoff IK, Chan TA. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci USA 2009;106:9435.
   PubMed Web of Science ®Google Scholar
• Lambert SR, Harwood CA, Purdie KJ, Gulati A, Matin RN, Romanowska M, Cerio R, Kelsell DP, Leigh IM, Proby CM. Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene. Int J Cancer 2011; Epub ahead of print.
   Web of Science ®Google Scholar
• De Preter K, Vandesompele J, Heimann P, Yigit N. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol 2006;7:R84.
   PubMed Web of Science ®Google Scholar
• Stallings RL, Nair P, Maris JM, Catchpoole D, McDermott M, O'Meara A, Breatnach F. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res 2006;66:3673.
   PubMed Web of Science ®Google Scholar
• Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J, Westerman BA, van Arkel J, Ebus ME, Haneveld F, Lakeman A, Schild L, Molenaar P, Stroeken P, van Noesel MM, Ora I, Santo EE, Caron HN, Westerhout EM, Versteeg R. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 2012;483:589.
   PubMed Web of Science ®Google Scholar
• Nair P, Depreter K, Vandesompele J, Speleman F, Stallings RL. Aberrant splicing of the PTPRD gene mimics microdeletions identified at this locus in neuroblastomas. Genes Chromosomes Cancer 2008;47:197.
   PubMed Web of Science ®Google Scholar
• Pulido R, Serra Pages C, Tang M, Streuli M. The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1. Proc Natl Acad Sci USA 1995;92:11686.
   PubMed Web of Science ®Google Scholar
• Uetani N, Chagnon MJ, Kennedy TE, Iwakura Y, Tremblay ML. Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. J Neurosci 2006;26:5872.
   PubMed Web of Science ®Google Scholar
• Stepanek L, Stoker AW, Stoeckli E, Bixby JL. Receptor tyrosine phosphatases guide vertebrate motor axons during development. J Neurosci 2005;25:3813.
   PubMed Web of Science ®Google Scholar
• Ensslen-Craig S, Brady-Kalnay S. Receptor protein tyrosine phosphatases regulate neural development and axon guidance. Dev Biol 2004;275:12.
   PubMed Web of Science ®Google Scholar
• Dunah AW, Hueske E, Wyszynski M, Hoogenraad CC, Jaworski J, Pak DT, Simonetta A, Liu G, Sheng M. LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses. Nature Neurosci 2005;8:458.
   PubMed Web of Science ®Google Scholar
• Beltran PJ, Bixby JL. Receptor protein tyrosine phosphatases as mediators of cellular adhesion. Front Biosci 2003;8:D87.
   PubMed Web of Science ®Google Scholar
• Bixby JL. Ligands and signaling through receptor-type tyrosine phosphatases. IUBMB Life 2001;51:157.
   PubMed Web of Science ®Google Scholar
• Uetani N, Kato K, Ogura H, Mizuno K, Kawano K, Mikoshiba K, Yakura H, Asano M, Iwakura Y. Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. Embo J 2000;19:2775.
   PubMed Web of Science ®Google Scholar
• Pulido R, Krueger NX, Serra Pages C, Saito H, Streuli M. Molecular characterization of the human transmembrane protein-tyrosine phosphatase delta. Evidence for tissue-specific expression of alternative human transmembrane protein-tyrosine phosphatase delta isoforms. J Biol Chem 1995;270:6722.
   PubMed Web of Science ®Google Scholar
• Sommer L, Rao M, Anderson DJ. RPTP delta and the novel protein tyrosine phosphatase RPTP psi are expressed in restricted regions of the developing central nervous system. Dev Dyn 1997;208:48.
   PubMed Web of Science ®Google Scholar
• Mizuno K, Hasegawa K, Ogimoto M, Katagiri T, Yakura H. Developmental regulation of gene expression for the MPTP delta isoforms in the central nervous system and the immune system. FEBS Lett 1994;355:223.
   PubMed Web of Science ®Google Scholar
• Nair P, DePreter K, Vandesompele J, Speleman F, Stallings RL. Aberrant splicing of the PTPRD gene mimics microdeletions identified at this locus in neuroblastomas. Genes Chromosomes Cancer 2008;47:197.
   PubMed Web of Science ®Google Scholar
• Wang J, Bixby J. Receptor tyrosine phosphatase-δ is a homophilic, neurite-promoting cell adhesion molecule for CNS neurons. Mol Cell Neurosci 1999;14:370.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Brito MR, Bixby JL. Differential activities in adhesion and neurite growth of fibronectin type III repeats in the PTP-delta extracellular domain. Int J Dev Neurosci 2006;24:425.
   PubMed Web of Science ®Google Scholar
• Kohno T, Otsuka A, Girard L, Sato M, Iwakawa R, Ogiwara H, Sanchez-Cespedes M, Minna JD, Yokota J. A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes Cancer 2010;49:342.
   PubMed Web of Science ®Google Scholar
• den Hertog J, Ostman A, Böhmer F-D. Protein tyrosine phosphatases: regulatory mechanisms. Febs J 2008;275: 831.
   PubMed Web of Science ®Google Scholar
• Fox AN, Zinn K. The heparan sulfate proteoglycan syndecan is an in vivo ligand for the Drosophila LAR receptor tyrosine phosphatase. Curr Biol 2005;15:1701.
   Google Scholar
• Kwon S-K, Woo J, Kim S-Y, Kim H, Kim E. Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases lar, PTPdelta, and PTPsigma via specific domains regulate excitatory synapse formation. J Biol Chem 2010;285:13966.
   PubMed Web of Science ®Google Scholar
• Johnson KG, Tenney AP, Ghose A, Duckworth AM, Higashi ME, Parfitt K, Marcu O, Heslip TR, Marsh JL, Schwarz TL, Flanagan JG, Van Vactor D. The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development. Neuron 2006;49:517.
   PubMed Web of Science ®Google Scholar
• Aricescu AR, McKinnell IW, Halfter W, Stoker AW. Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol Cell Biol 2002;22:1881.
   PubMed Web of Science ®Google Scholar
• Shen Y, Tenney AP, Busch SA, Horn KP, Cuascut FX, Liu K, He Z, Silver J, Flanagan JG. PTP sigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009;326:592.
   PubMed Web of Science ®Google Scholar
• Jia Z, Barford D, Flint AJ, Tonks NK. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science 1995;268:1754.
   PubMed Web of Science ®Google Scholar
• SerraPages C, Saito H, Streuli M. Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase. J Biol Chem 1994;269:23632.
   PubMed Web of Science ®Google Scholar
• Huber K. The sympathoadrenal cell lineage: specification, diversification, and new perspectives. Dev Biol 2006;298:335.
   Google Scholar
• Meehan M, Parthasarathi L, Moran N, Jefferies CA, Foley N, Lazzari E, Murphy D, Ryan J, Ortiz B, Fabius AW, Chan TA, Stallings RL. Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase a oncogene. Mol Cancer 2012;11:6.
   PubMed Web of Science ®Google Scholar
• Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB, Paty PB, Rohle D, Vivanco I, Chmielecki J, Pao W, Ladanyi M, Gerald WL, Liau L, Cloughesy TC, Mischel PS, Sander C, Taylor B, Schultz N, Major J, Heguy A, Fang F, Mellinghoff IK, Chan TA. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci USA 2009;106: 9435.
   PubMed Web of Science ®Google Scholar
• Woodings JA, Sharp SJ, Machesky LM. MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochem J 2003;371:463.
   PubMed Web of Science ®Google Scholar
• Birner P, Toumangelova-Uzeir K, Natchev S, Guentchev M. STAT3 tyrosine phosphorylation influences survival in glioblastoma. J Neurooncol 2010;100:339.
   PubMed Web of Science ®Google Scholar
• Barr AJ, Ugochukwu E, Lee WH, King ONF, Filippakopoulos P, Alfano I, Savitsky P, Burgess-Brown NA, Müller S, Knapp S. Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 2009;136:352.
   PubMed Web of Science ®Google Scholar
• Uetani N, Bertozzi K, Chagnon MJ, Hendriks W, Tremblay ML, Bouchard M. Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases. J Clin Invest 2009;119:924.
   PubMed Web of Science ®Google Scholar
• Faux C, Hawadle M, Nixon J, Wallace A, Lee S, Murray S, Stoker A. PTP sigma binds and dephosphorylates neurotrophin receptors and can suppress NGF-dependent neurite outgrowth from sensory neurons. Biochim Biophys Acta 2007;1773:1689.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Arstikaitis P, Prasad T, Bartlett TE, Wang YT, Murphy TH, Craig AM. Postsynaptic TrkC and presynaptic PTP sigma function as a bidirectional excitatory synaptic organizing complex. Neuron 2011;69:287.
   PubMed Web of Science ®Google Scholar
• Yang T, Massa SM, Longo FM. LAR protein tyrosine phosphatase receptor associates with TrkB and modulates neurotrophic signaling pathways. J Neurobiol 2006;66:1420.
   PubMedGoogle Scholar
• Morris LG, Taylor BS, Bivona TG, Gong Y, Eng S, Brennan CW, Kaufman A, Kastenhuber ER, Banuchi VE, Singh B, Heguy A, Viale A, Mellinghoff IK, Huse J, Ganly I, Chan TA. Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers. Proc Natl Acad Sci USA 2011;108:19024.
   PubMed Web of Science ®Google Scholar